Caption Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Caption Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,000	Closed	-$544K	–	1368
2020 Q3	$544K	Hold	30,000	–	–	0.01%	758
2020 Q2	$412K	Sell	30,000 -51,600	-63%	-$796K	0.01%	705
2020 Q1	$1.17M	Buy	81,600 +27,600	+51%	+$453K	0.07%	365
2019 Q4	$915K	Buy	+54,000	New	+$1M	0.03%	522

Caption Management's AKCA Position: Q4 2020 in Review

Caption Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 24,000 shares — an estimated $435K sold.

Caption Management first reported a position in AKCA in Q4 2019 and held it in 4 quarters. The position peaked at $435K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Caption Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Caption Management sold 24,000 Akcea Therapeutics Inc shares in Q4 2020, an estimated $435K.
Caption Management first reported a position in Akcea Therapeutics Inc in Q4 2019 and held it in 4 quarters.
Caption Management's Akcea Therapeutics Inc position peaked at $435K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Caption Management's 13F filing for Q4 2020, filed 16 Feb 2021.